prostate cancer risk from bph hair loss drugs
Last Updated : GMT 09:07:40
Egypt Today, egypt today
Egypt Today, egypt today
Last Updated : GMT 09:07:40
Egypt Today, egypt today

Prostate cancer risk from bph, hair loss drugs

Egypt Today, egypt today

Egypt Today, egypt today Prostate cancer risk from bph, hair loss drugs

Washington - Tehran

The prostate drugs Proscar, Avodart, and Jalyn and the hair-loss drug Propecia add to the risk of high-grade prostate cancer, the FDA warns. All of the drugs must change their labels to warn of the risk, which unexpectedly appeared in two different large-scale clinical trials. Ironically, Proscar and Avodart appear to reduce the risk of low-grade prostate cancer, which is less aggressive than high-grade prostate cancer. But the increased risk of high-grade prostate cancer means the drugs can't claim to lower overall prostate cancer risk. The FDA ruling follows the December 2010 vote of an FDA advisory panel, which rejected requests from Merck (for Proscar) and GlaxoSmithKline (for Avodart) to claim that the drugs prevent prostate cancer. The male hair-loss drug Propecia has the same active ingredient as Proscar, although at one-fifth the dose. But the FDA says Propecia should carry the same prostate cancer warning as Proscar. Even though the drugs are linked to prostate cancer, the risk is small. Men who are taking Proscar, Avodart, or Jalyn for benign prostatic hyperplasia (BPH) should not stop taking their medications, but should consult their doctors about their prostate cancer risk. Proscar, Avodart, and Propecia are in the same class of drugs, known as 5-alpha-reductase inhibitors or 5-ARIs. Jalyn has the same active ingredient as Avodart, together with a drug called tamsulosin (Flomax). The FDA warning does not include Flomax, which is in a different class of prostate drugs called alpha blockers. Other alpha blockers include Cardura, Hytrin, Uroxatral, and Rapaflo. Unlike the 5-ARI drugs, the alpha blockers are effective in treating the symptoms of BPH but have not been shown to reduce the risk of urinary retention due to an enlarged prostate.

egypttoday
egypttoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

prostate cancer risk from bph hair loss drugs prostate cancer risk from bph hair loss drugs



GMT 14:11 2017 Monday ,24 April

BMW reveals i8 Protonic special edition

GMT 12:30 2018 Friday ,14 December

Noriaki Kasai: 30 years of World Cup ski-jumping

GMT 12:55 2012 Tuesday ,20 March

Nominees for the Royal TV society programme

GMT 06:23 2012 Sunday ,18 March

Gol TV wants to offer cheap football

GMT 10:08 2012 Sunday ,08 July

I want to be a role model

GMT 11:23 2012 Thursday ,29 March

BalletBoyz the Talent mixed programme of 3 works

GMT 19:59 2011 Sunday ,16 October

Newlyweds Mike and Zara use package deal honeymoon

GMT 17:14 2014 Tuesday ,06 May

Colorful chic outdoor furniture

GMT 05:01 2012 Sunday ,15 April

Sky Germany takes TV everywhere with KIT digital

GMT 11:28 2018 Wednesday ,03 January

Saudi minister 'resumes work' after graft detention
 
 Egypt Today Facebook,egypt today facebook  Egypt Today Twitter,egypt today twitter Egypt Today Rss,egypt today rss  Egypt Today Youtube,egypt today youtube  Egypt Today Youtube,egypt today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

egypttoday egypttoday egypttoday egypttoday
egypttoday egypttoday egypttoday
egypttoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
egypttoday, Egypttoday, Egypttoday